VanEck Green Bond ETF (GRNB) Chart & Stock Price History → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free GRNB Stock Alerts $23.22 -0.03 (-0.13%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendHeadlinesHoldingsOwnershipStock AnalysisChartDividendHeadlinesHoldingsOwnership VanEck Green Bond ETF Stock Price Performance5 Day Performance-0.21%1 Month Performance-1.90%3 Month Performance-1.81%6 Month Performance+3.90%Year-To-Date Performance-2.55%1 Year Performance-1.65% Receive GRNB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Green Bond ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... GRNB Stock Chart for Thursday, April, 25, 2024 GRNB Chart by TradingView VanEck Green Bond ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$23.24$23.22-0.08%$23.23$23.133,011 shs$91.72 million04/24/2024$23.30$23.24-0.26%$23.26$23.246,352 shs$91.80 million04/23/2024$23.27$23.30+0.13%$23.33$23.308,167 shs$92.04 million04/22/2024$23.27$23.27$23.30$23.2216,253 shs$91.92 million04/19/2024$23.24$23.26+0.06%$23.28$23.243,256 shs$75.58 million04/18/2024$23.32$23.24-0.34%$23.26$23.2039,854 shs$75.53 million Get the Latest News and Ratings for GRNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Green Bond ETF and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$23.23$23.32+0.39%$23.33$23.2220,504 shs$75.79 million04/16/2024$23.24$23.23-0.04%$23.24$23.1661,644 shs$75.50 million04/15/2024$23.37$23.24-0.56%$23.29$23.237,455 shs$75.53 million04/12/2024$23.34$23.37+0.13%$23.40$23.3619,905 shs$75.95 million04/11/2024$23.38$23.34-0.17%$23.38$23.2550,922 shs$75.86 million04/10/2024$23.57$23.38-0.81%$23.45$23.368,904 shs$75.99 million04/09/2024$23.51$23.57+0.26%$23.59$23.543,622 shs$76.60 million04/08/2024$23.54$23.51-0.11%$23.53$23.504,488 shs$76.41 million04/05/2024$23.58$23.55-0.13%$23.57$23.534,662 shs$76.54 million04/04/2024$23.57$23.58+0.04%$23.58$23.548,425 shs$76.64 million04/03/2024$23.56$23.57+0.04%$23.57$23.4915,080 shs$76.60 million04/02/2024$23.57$23.56-0.04%$23.58$23.5013,014 shs$76.57 million04/01/2024$23.73$23.57-0.67%$23.61$23.5114,718 shs$76.60 million03/29/2024$23.73$23.73$23.80$23.6737,465 shs$77.12 million03/28/2024$23.76$23.73-0.13%$23.80$23.6737,465 shs$77.12 million03/27/2024$23.64$23.76+0.51%$23.76$23.7213,160 shs$77.22 million03/26/2024$23.67$23.64-0.13%$23.71$23.641,653 shs$76.83 million03/25/2024$23.72$23.67-0.21%$23.72$23.659,076 shs$76.93 million03/22/2024$23.67$23.73+0.25%$23.73$23.692,184 shs$77.12 million03/21/2024$23.67$23.67$23.69$23.639,890 shs$76.93 million03/20/2024$23.58$23.67+0.38%$23.67$23.6014,674 shs$76.93 million03/19/2024$23.55$23.58+0.13%$23.63$23.587,143 shs$76.64 million03/18/2024$23.57$23.55-0.06%$23.57$23.524,091 shs$76.54 million03/15/2024$23.60$23.58-0.11%$23.58$23.572,913 shs$76.62 million03/14/2024$23.68$23.60-0.34%$23.60$23.5811,311 shs$76.70 million03/13/2024$23.70$23.68-0.08%$23.69$23.656,543 shs$76.96 million03/12/2024$23.74$23.70-0.17%$23.71$23.6828,851 shs$77.03 million03/11/2024$23.76$23.74-0.06%$23.74$23.7012,549 shs$77.16 million03/08/2024$23.72$23.76+0.16%$23.78$23.749,170 shs$77.21 million03/07/2024$23.69$23.72+0.13%$23.72$23.696,829 shs$77.09 million03/06/2024$23.66$23.69+0.13%$23.72$23.6713,556 shs$76.99 million03/05/2024$23.61$23.66+0.21%$23.68$23.648,838 shs$76.90 million03/04/2024$23.61$23.610.00%$23.64$23.5931,925 shs$76.73 million03/01/2024$23.64$23.53-0.47%$23.62$23.5313,273 shs$76.47 millionJim Cramer’s “The Biggest Drug Ever” (Ad)This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here...02/29/2024$23.53$23.64+0.47%$23.64$23.592,777 shs$76.83 million02/28/2024$23.55$23.53-0.08%$23.59$23.535,598 shs$76.47 million02/27/2024$23.58$23.55-0.13%$23.57$23.533,975 shs$76.54 million02/26/2024$23.60$23.58-0.06%$23.62$23.5532,221 shs$76.63 million02/23/2024$23.53$23.56+0.15%$23.61$23.565,415 shs$76.57 million02/22/2024$23.54$23.53-0.06%$23.54$23.524,595 shs$76.46 million02/21/2024$23.57$23.54-0.13%$23.59$23.518,488 shs$76.51 million02/20/2024$23.51$23.57+0.26%$23.59$23.5612,184 shs$76.60 million02/19/2024$23.51$23.51$23.54$23.495,300 shs$76.41 million02/16/2024$23.58$23.50-0.34%$23.54$23.495,352 shs$76.38 million02/15/2024$23.51$23.58+0.30%$23.61$23.5410,060 shs$76.64 million02/14/2024$23.46$23.51+0.21%$23.52$23.475,779 shs$76.41 million02/13/2024$23.63$23.46-0.72%$23.51$23.4411,145 shs$76.25 million02/12/2024$23.61$23.63+0.09%$23.64$23.597,989 shs$76.80 million02/09/2024$23.63$23.59-0.17%$23.62$23.592,264 shs$76.67 million02/08/2024$23.67$23.63-0.17%$23.65$23.6211,214 shs$76.80 million02/07/2024$23.62$23.67+0.21%$23.69$23.6413,106 shs$76.93 million02/06/2024$23.61$23.62+0.04%$23.68$23.595,330 shs$76.77 million02/05/2024$23.69$23.61-0.34%$23.61$23.587,202 shs$76.73 million02/02/2024$23.85$23.70-0.63%$23.74$23.688,697 shs$77.03 million02/01/2024$23.79$23.85+0.25%$23.86$23.8110,922 shs$77.51 million01/31/2024$23.76$23.79+0.13%$23.86$23.794,215 shs$77.32 million01/30/2024$23.72$23.76+0.17%$23.76$23.704,643 shs$77.22 million01/29/2024$23.65$23.72+0.30%$23.74$23.687,207 shs$77.09 million01/26/2024$23.65$23.67+0.06%$23.70$23.6412,312 shs$76.91 million01/25/2024$23.57$23.65+0.34%$23.67$23.646,264 shs$76.86 million01/24/2024$23.62$23.57-0.21%$23.66$23.577,888 shs$76.61 million Related Companies: DTEC Stock Chart GNOM Stock Chart GEX Stock Chart XITK Stock Chart ONLN Stock Chart WGMI Stock Chart BETZ Stock Chart AWAY Stock Chart WCBR Stock Chart ACTV Stock Chart Receive GRNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VanEck Green Bond ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:GRNB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & CompanyKeep Your Eyes on This Power-Mad PoliticianAltimetry"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Green Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.